{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:15:15Z","timestamp":1791303315242,"version":"4.1.0"},"reference-count":46,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Iron deficiency\/excess may be associated with worse prognosis in patients undergoing hemodialysis. This study ascertained the association of the estimated total body iron (TBI) with mortality in patients receiving hemodialysis. Multicenter clinical data collected in the Miyazaki Dialysis Cohort Study from 943 patients receiving hemodialysis were analyzed after stratification into tertile categories by baseline TBI\u2014estimated as the heme iron plus iron storage from ferritin levels. The primary outcome was a 5-year all-cause mortality; hazard ratios of the TBI\u2013all-cause mortality association were estimated using Cox models adjusted for potential confounders, including clinical characteristics, laboratory, and drug data, wherein patients with high TBI were the reference category. The receiver operating characteristic (ROC) curve analyses of TBI, serum ferritin levels, and transferrin saturation were performed to predict all-cause mortality; a total of 232 patients died during the follow-up. The low TBI group (&lt;1.6 g) had significantly higher hazard ratios of mortality than the high TBI group (\u22652.0 g). As ROC curve analyses showed, TBI predicted mortality more accurately than either levels of serum ferritin or transferrin saturation. Lower TBI increases the mortality risk of Japanese hemodialysis patients, and further studies should examine whether iron supplementation therapy that avoids low TBI improves prognosis.<\/jats:p>","DOI":"10.3390\/nu15214658","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T02:41:56Z","timestamp":1698979316000},"page":"4658","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association of Estimated Total Body Iron with All-Cause Mortality in Japanese Hemodialysis Patients: The Miyazaki Dialysis Cohort Study"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0135-599X","authenticated-orcid":false,"given":"Tatsunori","family":"Toida","sequence":"first","affiliation":[{"name":"School of Pharmaceutical Sciences, Kyushu University of Health and Welfare, Nobeoka City 882-8508, Miyazaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1272-4108","authenticated-orcid":false,"given":"Yuji","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology, National Health Insurance Takachiho Town Hospital, Takachiho 889-1101, Miyazaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Center for Medical Education and Career Development, Faculty of Medicine, University of Miyazaki, Miyazaki City 889-16095, Miyazaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0025-4030","authenticated-orcid":false,"given":"Shouichi","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Department of Medical Environment Innovation, Faculty of Medicine, University of Miyazaki, Miyazaki City 889-1609, Miyazaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.tracli.2017.06.015","article-title":"Iron metabolism: State of the art","volume":"24","author":"Daher","year":"2017","journal-title":"Transfus. Clin. Biol."},{"key":"ref_2","unstructured":"(2012). KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int. Suppl., 2, 279\u2013335."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s41100-017-0114-y","article-title":"2015 Japanese Society for Dialysis Therapy: Guidelines for renal anemia in chronic kidney disease","volume":"3","author":"Yamamoto","year":"2017","journal-title":"Ren. Replace. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000368391","article-title":"A randomized control study on the procedure for switching epoetin beta (EPO) to epoetin beta pegol (CERA) in the treatment of renal anemia in maintenance hemodialysis patients","volume":"38","author":"Toida","year":"2014","journal-title":"Blood Purif."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1159\/000320733","article-title":"Importance of ferritin for optimizing anemia therapy in chronic kidney disease","volume":"32","author":"Nakanishi","year":"2010","journal-title":"Am. J. Nephrol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1182\/blood-2009-02-201087","article-title":"Proinflammatory state, hepcidin, and anemia in older persons","volume":"115","author":"Ferrucci","year":"2010","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1159\/000191470","article-title":"Association of serum total iron-binding capacity and its changes over time with nutritional and clinical outcomes in hemodialysis patients","volume":"29","author":"Bross","year":"2009","journal-title":"Am. J. Nephrol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ab.2009.03.039","article-title":"(Pre)analytical imprecision, between-subject variability, and daily variations in serum and urine hepcidin: Implications for clinical studies","volume":"389","author":"Kroot","year":"2009","journal-title":"Anal. Biochem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/clinchem\/25.10.1799","article-title":"Intra-individual variation in commonly analyzed serum constituents","volume":"25","author":"Morrison","year":"1979","journal-title":"Clin. Chem."},{"key":"ref_10","first-page":"3","article-title":"Circadian periodicity of the results of frequently used laboratory tests in elderly subjects","volume":"21","author":"Nicolau","year":"1983","journal-title":"Endocrinologie"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2215\/CJN.01490506","article-title":"Assessing iron status: Beyond serum ferritin and transferrin saturation","volume":"1","author":"Wish","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000499758","article-title":"Impact of transferrin saturation on all-cause mortality in patients on maintenance hemodialysis","volume":"48","author":"Sato","year":"2019","journal-title":"Blood Purif."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Kuragano, T., Joki, N., Hase, H., Kitamura, K., Murata, T., Fujimoto, S., Fukatsu, A., Inoue, T., Itakura, Y., and Nakanishi, T. (2020). Low transferrin saturation (TSAT) and high ferritin levels are significant predictors for cerebrovascular and cardiovascular disease and death in maintenance hemodialysis patients. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0236277"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000358336","article-title":"Efficacy and safety of intravenous iron therapy for functional iron deficiency anemia in hemodialysis patients: A meta-analysis","volume":"39","author":"Susantitaphong","year":"2014","journal-title":"Am. J. Nephrol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1681\/ASN.2020101531","article-title":"Serum biomarkers of iron stores are associated with increased risk of all-cause mortality and cardiovascular events in nondialysis CKD patients, with or without anemia","volume":"32","author":"Guedes","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1093\/ndt\/gfy190","article-title":"Association between serum ferritin and mortality: Findings from the USA, Japan and European dialysis outcomes and practice patterns study","volume":"33","author":"Karaboyas","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10157-016-1317-1","article-title":"Both low and high serum ferritin levels predict mortality risk in hemodialysis patients without inflammation","volume":"21","author":"Shoji","year":"2017","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.kint.2021.03.020","article-title":"Controversies in optimal anemia management: Conclusions from a kidney disease: Improving global outcomes (KDIGO) conference","volume":"99","author":"Babitt","year":"2021","journal-title":"Kidney Int."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1111\/trf.13659","article-title":"Effect of iron supplementation on iron stores and total body iron after whole blood donation","volume":"56","author":"Cable","year":"2016","journal-title":"Transfusion"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0021-9258(18)72406-X","article-title":"The iron content of crystallized human hemoglobin","volume":"147","author":"Bernhart","year":"1943","journal-title":"J. Biol. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1053\/j.ajkd.2008.02.360","article-title":"Therapeutic plasma exchange: Core curriculum 2008","volume":"52","author":"Kaplan","year":"2008","journal-title":"Am. J. Kidney Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1172\/JCI102859","article-title":"The body\/venous hematocrit ratio: Its constancy over a wide hematocrit range","volume":"32","author":"Chaplin","year":"1953","journal-title":"J. Clin. Investig."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijcard.2016.03.039","article-title":"Intravenous iron sucrose reverses anemia-induced cardiac remodeling, prevents myocardial fibrosis, and improves cardiac function by attenuating oxidative\/nitrosative stress and inflammation","volume":"212","author":"Toblli","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ejhf.84","article-title":"The additive burden of iron deficiency in the cardiorenal-anaemia axis: Scope of a problem and its consequences","volume":"16","author":"Klip","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.blre.2017.02.004","article-title":"New insights into iron deficiency and iron deficiency anemia","volume":"31","author":"Camaschella","year":"2017","journal-title":"Blood Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/ndt\/gfz192","article-title":"Prevalence, correlates, and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease","volume":"36","author":"Awan","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Eisenga, M.F., Nolte, I.M., van der Meer, P., Bakker, S.J.L., and Gaillard, C.A.J.M. (2018). Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease. BMC Nephrol., 19.","DOI":"10.1186\/s12882-018-1021-3"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1681\/ASN.2005040423","article-title":"Time-dependent associations between iron and mortality in hemodialysis patients","volume":"16","author":"Regidor","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ki.2014.275","article-title":"Data from the dialysis outcomes and practice patterns study validate an association between high intravenous iron doses and mortality","volume":"87","author":"Bailie","year":"2015","journal-title":"Kidney Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.2215\/CJN.03370414","article-title":"Intravenous iron exposure and mortality in patients on hemodialysis","volume":"9","author":"Miskulin","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1097\/01.ASN.0000128009.69594.BE","article-title":"Administration of parenteral iron and mortality among hemodialysis patients","volume":"15","author":"Feldman","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/ndt\/gfu349","article-title":"Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: A comparative effectiveness analysis from the DEcIDE-ESRD study","volume":"30","author":"Tangri","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2215\/CJN.05390517","article-title":"Safety of intravenous iron in dialysis: A systematic review and meta-analysis","volume":"13","author":"Hougen","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa1810742","article-title":"Intravenous iron in patients undergoing maintenance hemodialysis","volume":"380","author":"Macdougall","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1523-1755.2004.00480.x","article-title":"Validation of serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients","volume":"65","author":"Canavese","year":"2004","journal-title":"Kidney Int."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.CIR.0000035250.66458.67","article-title":"Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end stage renal disease","volume":"106","author":"Massy","year":"2002","journal-title":"Circulation"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Kuo, K.L., Hung, S.C., Lin, Y.P., Tang, C.F., Lee, T.S., Lin, C.P., and Tarng, D.C. (2012). Intravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0050295"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1681\/ASN.2013080838","article-title":"Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD","volume":"25","author":"Kuo","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s40265-016-0569-0","article-title":"Iatrogenic iron overload in dialysis patients at the beginning of the 21st century","volume":"76","author":"Rostoker","year":"2016","journal-title":"Drugs"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.kint.2019.04.029","article-title":"An increased mortality risk is associated with abnormal iron status in diabetic and non-diabetic Veterans with predialysis chronic kidney disease","volume":"96","author":"Cho","year":"2019","journal-title":"Kidney Int."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/ckj\/sfaa212","article-title":"Intravenous iron therapy and the cardiovascular system: Risks and benefits","volume":"14","author":"Ekart","year":"2021","journal-title":"Clin. Kidney J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1131516","DOI":"10.3389\/fendo.2023.1131516","article-title":"Effects of hypoxia-inducible factor-prolyl hydroxylase inhibitors vs. erythropoiesis-stimulating agents on iron metabolism in non-dialysis-dependent anemic patients with CKD: A network meta-analysis","volume":"14","author":"Yang","year":"2023","journal-title":"Front. Endocrinol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000336528","article-title":"Serum hemojuvelin and hepcidin levels in chronic kidney disease","volume":"35","author":"Rumjon","year":"2012","journal-title":"Am. J. Nephrol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Maruyama, Y., Yokoyama, K., Yokoo, T., Shigematsu, T., Iseki, K., and Tsubakihara, Y. (2015). The different association between serum ferritin and mortality in hemodialysis and peritoneal dialysis patients using Japanese nationwide dialysis registry. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0143430"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199808273390903","article-title":"The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin","volume":"339","author":"Besarab","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.7326\/0003-4819-153-1-201007060-00252","article-title":"Meta-analysis: Erythropoiesis-stimulating agents in patients with chronic kidney disease","volume":"153","author":"Palmer","year":"2010","journal-title":"Ann. Intern. Med."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/15\/21\/4658\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:16:23Z","timestamp":1760130983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/15\/21\/4658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,3]]},"references-count":46,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["nu15214658"],"URL":"https:\/\/doi.org\/10.3390\/nu15214658","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,3]]}}}